Actionable news
0
All posts from Actionable news
Actionable news in RNN: REXAHN PHARMACEUTICALS Inc,

On November

Section 9 - Financial Statements and Exhibits

Item 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.

Description

5.1

Opinion of Hogan Lovells US LLP.

23.1

Consent of Hogan Lovells US LLP (included in Exhibit 5.1).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934...


More